Cargando…

Case Report: Vortioxetine in the Treatment of Depressive Symptoms in Patients With Epilepsy—Case Series

Epilepsy and depression are both serious and potentially disabling conditions which often coexist—bidirectional relationship between the two disorders has been observed. Comorbidity between depression and epilepsy can be attributed to: underlying common pathophysiological mechanisms, psychiatric sid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Siwek, Marcin, Gorostowicz, Aleksandra, Bosak, Magdalena, Dudek, Dominika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009204/ https://www.ncbi.nlm.nih.gov/pubmed/35431973 http://dx.doi.org/10.3389/fphar.2022.852042

Ejemplares similares

Withdrawal Symptoms Following Discontinuation of Vortioxetine—Retrospective Chart Review
por: Siwek, Marcin, et al.
Publicado: (2021)

TED—trazodone effectiveness in depression: a naturalistic study of the effeciveness of trazodone in extended release formulation compared to SSRIs in patients with a major depressive disorder
por: Dudek, Dominika, et al.
Publicado: (2023)

Depressogenic medications and other risk factors for depression among Polish patients with epilepsy
por: Bosak, Magdalena, et al.
Publicado: (2015)

Lurasidone in Therapy of Treatment-resistant Ultra-rapid Cycling Bipolar Disorder: Case Report
por: Siwek, Marcin, et al.
Publicado: (2021)

TED—Trazodone Efficacy in Depression: A Naturalistic Study on the Efficacy of Trazodone in an Extended-Release Formulation Compared to SSRIs in Patients with a Depressive Episode—Preliminary Report
por: Siwek, Marcin, et al.
Publicado: (2023)

Lurasidone Augmentation of Clozapine in Schizophrenia—Retrospective Chart Review
por: Siwek, Marcin, et al.
Publicado: (2023)

Efficacy of vortioxetine on the physical symptoms of major depressive disorder
por: Christensen, Michael Cronquist, et al.
Publicado: (2018)

Polish adaptation of the Dimensional Anhedonia Rating Scale (DARS) - validation in the clinical sample
por: Gorostowicz, Aleksandra, et al.
Publicado: (2023)

Major depression with musical obsession treated with vortioxetine: a case report
por: Yoshimura, Reiji, et al.
Publicado: (2021)

Impact of Vortioxetine on Synaptic Integration in Prefrontal-Subcortical Circuits: Comparisons with Escitalopram
por: Chakroborty, Shreaya, et al.
Publicado: (2017)

Clinical efficacy of Vortioxetine and escitalopram in the treatment of depression
por: Shao, Shichuan, et al.
Publicado: (2022)

Vortioxetine Improves Context Discrimination in Mice Through a Neurogenesis Independent Mechanism
por: Felice, Daniela, et al.
Publicado: (2018)

Inhibitory mechanism of vortioxetine on CYP450 enzymes in human and rat liver microsomes
por: Zhan, Yunyun, et al.
Publicado: (2023)

Vortioxetine Prevents Lipopolysaccharide-Induced Memory Impairment Without Inhibiting the Initial Inflammatory Cascade
por: Alboni, S., et al.
Publicado: (2021)

Antioxidant Activity of Fluoxetine and Vortioxetine in a Non-Transgenic Animal Model of Alzheimer’s Disease
por: Caruso, Giuseppe, et al.
Publicado: (2021)

When practice does not make a perfect - paradoxical learning curve in schizophrenia and bipolar disorder revealed by different serial reaction time task variants
por: Chrobak, Adrian Andrzej, et al.
Publicado: (2023)

The Gut-Brain-Axis on the Manifestation of Depressive Symptoms in Epilepsy: An Evidence-Driven Hypothesis
por: Shaikh, Mohd. Farooq, et al.
Publicado: (2020)

Lipid Peroxidation and Immune Biomarkers Are Associated with Major Depression and Its Phenotypes, Including Treatment-Resistant Depression and Melancholia
por: Sowa-Kućma, Magdalena, et al.
Publicado: (2017)

Status epilepticus in patients with genetic (idiopathic) generalized epilepsy
por: Bosak, Magdalena, et al.
Publicado: (2019)

Vortioxetine Treatment Reverses Subchronic PCP Treatment-Induced Cognitive Impairments: A Potential Role for Serotonin Receptor-Mediated Regulation of GABA Neurotransmission
por: Pehrson, Alan L., et al.
Publicado: (2018)

Hippocampal PPARα Plays a Role in the Pharmacological Mechanism of Vortioxetine, a Multimodal-Acting Antidepressant
por: Wang, Yuan, et al.
Publicado: (2021)

Pharmacology and clinical potential of vortioxetine in the treatment of major depressive disorder
por: Alvarez, Enric, et al.
Publicado: (2014)

Vortioxetine Differentially Modulates MK-801-Induced Changes in Visual Signal Detection Task Performance and Locomotor Activity
por: Hillhouse, Todd M., et al.
Publicado: (2018)

Vortioxetine Improved Depressive State In Parkinson’s Disease
por: Yoshimura, Reiji, et al.
Publicado: (2021)

Vortioxetine overdose in a suicidal attempt: A case report
por: Mazza, Mario Gennaro, et al.
Publicado: (2018)

Fluoxetine and Vortioxetine Reverse Depressive-Like Phenotype and Memory Deficits Induced by Aβ(1-42) Oligomers in Mice: A Key Role of Transforming Growth Factor-β1
por: Torrisi, Sebastiano Alfio, et al.
Publicado: (2019)

Emotional blunting and cognitive profile in elderly depressed patients in treatment with vortioxetine
por: Franza, F., et al.
Publicado: (2021)

A Case of Major Depression with Burning Mouth Syndrome and Tinnitus Successfully Treated with Vortioxetine
por: Yoshimura, Reiji, et al.
Publicado: (2021)

Vortioxetine improves physical and cognitive symptoms in patients with post-COVID-19 major depressive episodes
por: Di Nicola, Marco, et al.
Publicado: (2023)

Vortioxetine Improves Depressive Symptoms and Cognition in Parkinson’s Disease Patients with Major Depression: An Open-Label Prospective Study
por: Santos García, Diego, et al.
Publicado: (2022)

The Efficacy of Vortioxetine on Anhedonia in Patients With Major Depressive Disorder
por: Cao, Bing, et al.
Publicado: (2019)

Recovery of Visual Scotomas by Vortioxetine in a Patient with Symptomatic Occipital Lobe Epilepsy
por: Onder, Halil, et al.
Publicado: (2018)

Vortioxetine as adjunctive therapy in the treatment of schizophrenia
por: Redaelli, Sofia, et al.
Publicado: (2022)

Depression and Cerebrovascular Disease: Could Vortioxetine Represent a Valid Treatment Option?
por: Carta, Mauro Giovanni, et al.
Publicado: (2015)

Profile of vortioxetine in the treatment of major depressive disorder: an overview of the primary and secondary literature
por: Kelliny, Marc, et al.
Publicado: (2015)

Systematic Review and Meta-Analysis of Vortioxetine for the Treatment of Major Depressive Disorder in Adults
por: Zhang, Xinyan, et al.
Publicado: (2022)

Case Report of Novel Genetic Variant in KCNT1 Channel and Pharmacological Treatment With Quinidine. Precision Medicine in Refractory Epilepsy
por: Kravetz, M. C., et al.
Publicado: (2021)

Comorbid epilepsy and depression—pharmacokinetic and pharmacodynamic drug interactions
por: Miziak, Barbara, et al.
Publicado: (2022)

Postpartum depression: bipolar or unipolar? Analysis of 434 Polish postpartum women
por: Jaeschke, Rafał R., et al.
Publicado: (2016)

Study of the Serum Copper Levels in Patients with Major Depressive Disorder
por: Styczeń, Krzysztof, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ss05g87dmb9hhl1dbsm2pmr5v4